GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹13,322 Cr | ₹11,813 Cr | ₹11,583 Cr | ₹12,305 Cr | ₹10,944 Cr |
What is the latest Revenue of GLENMARK PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹13,322 Cr |
| Mar2025 | ₹11,813 Cr |
| Mar2024 | ₹11,583 Cr |
| Mar2023 | ₹12,305 Cr |
| Mar2022 | ₹10,944 Cr |
How is Revenue of GLENMARK PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹13,322 Cr | 12.77 | |
| Mar2025 | ₹11,813 Cr | 1.98 | |
| Mar2024 | ₹11,583 Cr | -5.86 | |
| Mar2023 | ₹12,305 Cr | 12.44 | |
| Mar2022 | ₹10,944 Cr | - | |
Compare Revenue of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹63,636.1 Cr | 1.6% | 3.1% | 13.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 1.6% |
3.1% |
13.6% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses